SCIENTIFIC LITERATURE · MED

Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.

Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O, BouNDless Study Group.

Lancet Neurol · 2024-03-15

DOI: 10.1016/s1474-4422(24)00052-8PMID: 38499015

Check source for accessClinical Trial, Phase III; Research Support, Non-U.S. Gov't; Multicenter Study; Randomized Controlled Trial; Journal ArticleOriginal source ↗

Research overview

Read the abstract at its original source.

A license permitting republication of the abstract has not been verified for this record. Follow the original publication using its title, authors and identifiers.

Read the original publication ↗

Scientific assessment

Research question

Assess the question within the original study’s scope.

Methods & sample

Check the source article for study design and sample details.

Key findings

An editorially approved findings summary is not yet published for this record.

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.